• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC SILIKON 1000 OIL; FLUID, INTRAOCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC SILIKON 1000 OIL; FLUID, INTRAOCULAR Back to Search Results
Catalog Number 8065601187
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hypopyon (1913); Toxic Anterior Segment Syndrome (TASS) (4469); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 10/26/2021
Event Type  Injury  
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event Description
A nurse reported that a patient experienced tass toxic anterior segment syndrome (tass) after the surgery.Additional information has been requested.Additional information received indicated after the vitrectomy with laser, silicone oil, membrane peel surgery the event occurred.Four + aqueous cell and hypopyon was noted.Three sutures were required and patient was prescribed with post-operative antibiotic.Cultures were performed.Vision improved and patient condition is improving.
 
Manufacturer Narrative
Received 2 unopened cartons, containing 2 unopened vials,.No anomalies observed.The reporting facility does not know the lot code of the vials used in the procedure nor do they have the used product available for return.The 2 vials of product is from their inventory.Review of the complaint history shows no other similar complaint reported.Review of the mbr record of the lot number provided indicated that product was processed and released according to the product's acceptance criteria.Vial is compounded by (1) chemical and thermal extraction, and (2) sterile filtration of oil prior to filling.The product is then filled into its primary packaging components using aseptic processing.The product is terminally sterilized using dry heat.Following sterilization, units are 200% inspected for particulate in the solution and then packaged into pouches and sealed.The root cause of complaint condition could not be determined.Potential root cause includes: solution quality issue ¿ highly unlikely, as chemistry and microbiology data is reviewed and verified to meet regulatory requirements prior to release.Consumer mishandling - no conclusion can be made regarding the contribution of consumer mishandling as this factor is outside the control of the manufacturing facility.Event outside of manufacturer¿s control (product storage, use, and surgical practice); this could not be confirmed.A comprehensive review was performed including a review of the processes, complaint histories, batch record review, finished product testing results.The review shows that the manufacturing processes were in a state of control.Based on the acceptable mbr review and finished product test results, this lot continues to be acceptable.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SILIKON 1000 OIL
Type of Device
FLUID, INTRAOCULAR
Manufacturer (Section D)
ALCON RESEARCH, LLC
6201 south freeway
fort worth TX 76134
Manufacturer (Section G)
ALCON RESEARCH, LLC
6201 south freeway
fort worth TX 76134
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key12879880
MDR Text Key281318825
Report Number1610287-2021-00032
Device Sequence Number1
Product Code LWL
UDI-Device Identifier00380656011873
UDI-Public00380656011873
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P950008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 02/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/27/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2023
Device Catalogue Number8065601187
Device Lot Number10NJF
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/27/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/28/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/09/2021
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BSS PLUS IRRIGATING SOLUTION.
Patient Outcome(s) Required Intervention; Other;
Patient Age49 YR
Patient SexMale
-
-